These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 18292189

  • 41. The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients.
    Richir MC, Ellger B, Teerlink T, Siroen MP, Visser M, Spreeuwenberg M, Girbes AR, van der Hoven B, van den Berghe G, Wilhelm AJ, de Vries TP, van Leeuwen PA.
    Pharmacol Res; 2009 Dec; 60(6):519-24. PubMed ID: 19559792
    [Abstract] [Full Text] [Related]

  • 42. DdaR (PA1196) Regulates Expression of Dimethylarginine Dimethylaminohydrolase for the Metabolism of Methylarginines in Pseudomonas aeruginosa PAO1.
    Lundgren BR, Bailey FJ, Moley G, Nomura CT.
    J Bacteriol; 2017 Apr 15; 199(8):. PubMed ID: 28167521
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD).
    Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.
    Life Sci; 2009 Jun 05; 84(23-24):853-6. PubMed ID: 19351540
    [Abstract] [Full Text] [Related]

  • 45. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
    Servillo L, Giovane A, Cautela D, Castaldo D, Balestrieri ML.
    Nitric Oxide; 2013 Apr 01; 30():43-8. PubMed ID: 23438481
    [Abstract] [Full Text] [Related]

  • 46. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
    Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G.
    Diabetes; 2006 Apr 01; 55(4):1096-105. PubMed ID: 16567534
    [Abstract] [Full Text] [Related]

  • 47. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
    Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH.
    Shock; 2016 Oct 01; 46(4):365-72. PubMed ID: 27206279
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
    Trocha M, Nowak B, Merwid-Ląd A, Szuba A, Dzięgiel P, Pieśniewska M, Gomułkiewicz A, Wiśniewski J, Piasecki T, Gziut M, Szeląg A, Sozański T.
    Adv Clin Exp Med; 2018 Nov 01; 27(11):1483-1490. PubMed ID: 30303311
    [Abstract] [Full Text] [Related]

  • 50. Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.
    Krzyzanowska K, Mittermayer F, Schnack C, Hofer M, Wolzt M, Schernthaner G.
    Eur J Clin Invest; 2005 Mar 01; 35(3):208-13. PubMed ID: 15733076
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH.
    Eid HM, Lyberg T, Arnesen H, Seljeflot I.
    Atherosclerosis; 2007 Oct 01; 194(2):e1-8. PubMed ID: 17141242
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
    Quintana-Villamandos B, Delgado-Baeza E.
    Med Hypotheses; 2016 Feb 01; 87():44-7. PubMed ID: 26826640
    [Abstract] [Full Text] [Related]

  • 56. Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans.
    Mittermayer F, Namiranian K, Pleiner J, Schaller G, Wolzt M.
    Clin Sci (Lond); 2004 Jun 01; 106(6):577-81. PubMed ID: 14741043
    [Abstract] [Full Text] [Related]

  • 57. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy.
    Bełtowski J, Kedra A.
    Pharmacol Rep; 2006 Jun 01; 58(2):159-78. PubMed ID: 16702618
    [Abstract] [Full Text] [Related]

  • 58. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
    Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA.
    Clin Nutr; 2003 Feb 01; 22(1):23-30. PubMed ID: 12553946
    [Abstract] [Full Text] [Related]

  • 59. Possible indirect detection of rHuEPO administration in human urine by high-performance liquid chromatography tandem mass spectrometry.
    Appolonova SA, Dikunets MA, Rodchenkov GM.
    Eur J Mass Spectrom (Chichester); 2008 Feb 01; 14(3):201-9. PubMed ID: 18708700
    [Abstract] [Full Text] [Related]

  • 60. The biological effect of pharmacological treatment on dimethylaminohydrolases (DDAH-1) and cationic amino acid transporter-1 (CAT-1) expression in patients with acute congestive heart failure.
    Speranza L, Franceschelli S, D'Orazio N, Gaeta R, Bucciarelli T, Felaco M, Grilli A, Riccioni G.
    Microvasc Res; 2011 Nov 01; 82(3):391-6. PubMed ID: 21722652
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.